Gene interactions and pathways from curated databases and text-mining

◀ Back to NFKB1

HSP90AA1 — NFKB1

Pathways - manually collected, often from reviews:

  • WikiPathways EBV LMP1 signaling: Complex of IKBKG-CHUK-IKBKB-HSP90AA1 → Complex of NFKBIA-NFKB1-RELA (activation)

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Lewis et al., J Biol Chem 2000 : These data indicate that Hsp90 plays an important role in TNF mediated NF-kappaB activation by modulating the stability and solubility of RIP
Tago et al., Life Sci 2004 : Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1 ... Both tumor necrosis factor-alpha activated NF-kappaB and phorbol ester activated AP-1 were inhibited by Dex and Hsp90 inhibitors alone ... These results suggest that Hsp90 inhibitor itself inhibits the activation of NF-kappaB and AP-1, however, impedes Dex induced inhibition of IL-1beta induction by attenuating Dex mediated activation of GR and inhibition of the proinflammatory transcription factors
Yan et al., Autophagy 2007 (Cell Transformation, Viral) : We recently found that specific inhibition of Hsp90 by geldanamycin ( GA ) results in autophagic degradation of IKK and NFkappaB inducing kinase (NIK) , an upstream kinase of IKK, and inactivation of NFkappaB in various cell lines ... Here, we further report that GA inhibition of Hsp90 also led to IKK autophagic degradation and NFkappaB inhibition in both HTLV transformed T cells and ATL derived cell lines
Kim et al., Mol Cancer Res 2008 (Glioma) : Here, we report that the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin ( 17-AAG ) blocks MMP-9 secretion and that HA-induced nuclear factor-kappaB (NF-kappaB) activation is mediated by IkappaB kinase, which phosphorylates the NF-kappaB inhibitor IkappaBalpha and promotes its degradation
Myung et al., J Pharmacol Exp Ther 2009 : These results demonstrate that the Hsp90 inhibitor induces HSC apoptosis via a sphingomyelinase- and NFkappaB dependent mechanism